No Data
No Data
Channel Therapeutics CHRO +50% Merges With Ligand LGND Subsidiaries; Adagio Medical ADGM +94% Breakthrough Device Designation
Sector Update: Health Care Stocks Softer Thursday Afternoon
Channel Therapeutics Shares Are Trading Higher After the Company Announced That It Will Combine With Ligand Subsidiary Pelthos Therapeutics to Create a Pain Medicines Focused Entity.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Ligand Pharmaceuticals to Merge Units With Channel Therapeutics to Launch Pelthos Therapeutics
Ligand Pharmaceuticals and Channel Therapeutics Announce $50 Million Merger to Advance ZELSUVMI for Molluscum Contagiosum Treatment
Edozz : not sure but I dumped at -4% this morning bought AREB instead